Coronaviruses (CoV) are a group of enveloped, single-stranded (positive-sense) RNA viruses belonging to the nidoviral order, family Coronaviridae. They are an important family of pathogens that affect the human respiratory system can produce clinical pictures ranging from the common cold, with seasonal pattern in winter, to more serious ones such as those produced by severe acute respiratory syndrome (SARS) and Near East respiratory syndrome (MERS-CoV) viruses and the latter responsible for the great global pandemic, SAR-Cov2, which causes the COVID-19 disease that has spread worldwide with very efficient transmission and a higher case fatality rate than seasonal influenza. Diagnostic tools for the detection and monitoring of COVID-19 have become an indispensable requirement to quantify the number of cases around the world and from this point to be able to take the corresponding sanitary and political measures to give a forceful response to the outbreaks that are appearing. Testing is vital clinical diagnostic tool, and the techniques available so far have been based on detection of viral genes (such as RT-PCR reference technique), detection of antibodies and detection of viral antigens. Diagnosis has enormous potential in the fight against diseases and in obtaining better health outcomes in the population. The Covid-19 pandemic focused on the preparedness needed to assess, analyze and identify the different variables of health care. With the extensive use of quantitative reverse transcription-PCR (RT-PCR) technology, it is now possible to provide accurate and timely laboratory diagnostic test results to public health experts and other stakeholders in a robust manner. This contrasts sharply with the last influenza pandemic in 2009, in which diagnosis in many clinical settings was based primarily on clinical observations, resulting in an underestimation of the actual number of deaths caused by pandemic influenza A (H1N1) 2009 virus. Several studies worldwide show that diagnostic tests are an indispensable tool in clinical practice. First, because they provide critical information at every step of the patient pathway: from prognosis, preventive studies (screening), diagnosis to monitoring disease progression and predicting responses to treatment. And also because they play an increasingly important role in providing personalized, cost-effective, value-based healthcare. Even so, the value of diagnostic information is often not fully recognized by health systems. Diagnostic research and development helps develop products and solutions that lead to more patient-centered, outcome-based care. This helps enable healthcare professionals to make the right diagnoses at the right time.
This article explores the fundamental importance of implementing rapid tests in the diagnosis of dengue, emphasizing their essential role in early detection and efficient management of this mosquito-transmitted disease. These tests, based on the detection of viral antigens or specific antibodies, not only provide results in record time but also constitute a significant contribution to global healthcare. Rapid tests offer an immediate response, allowing timely medical intervention that can make a difference in the clinical course of the patient. Their ability to identify the virus in the early stages of infection is crucial, not only for individualized care but also for mitigating the spread of dengue at the community level. Moreover, by distinguishing between virus serotypes, these tests provide a more precise perspective for the application of therapeutic and preventive strategies. The accessibility and simplicity of rapid tests become key elements for their positive impact, especially in resource-limited settings. The swift availability of results not only accelerates clinical decision-making but also facilitates the collection of crucial epidemiological data. This information contributes to the strategic planning of public health authorities, enabling a coordinated and efficient response to dengue outbreaks and epidemics. The widespread adoption of rapid tests in dengue diagnosis emerges as a fundamental pillar in global healthcare. Their ability to provide rapid and accurate results, their role in early detection, and their contribution to efficient management make these tests an invaluable tool in the fight against this prevalent disease, redefining how we approach the diagnosis and treatment of dengue on a global scale.
The article "The value of communication in a pandemic" highlights the crucial importance of communication during a health crisis. It highlights how accurate and up-to-date information, accessibility and inclusiveness in communication, empathy and compassion in the way of communicating, and the proper use of technology are key elements for effective communication in times of pandemic. The benefits of effective communication are mentioned, such as preventing the spread of the virus, promoting responsible behaviour, managing misinformation and promoting solidarity and emotional support. The challenges facing communication in a pandemic, such as misinformation and inequality in access to information, are also recognized. of the spread of the virus, effective communication, Inequality in access to information, Well-being, Adaptation to the needs of the population. MATERIALS AND METHODS The materials used in this study include data from various sources, including databases, public health reports, and scientific literature. We conducted a comprehensive review of the literature on health communication in times of pandemic, using a systematic approach to identify relevant articles. We searched multiple databases, including PubMed, Scopus, and Web of Science, using keywords related to epidemiological surveillance and pandemics. We also reviewed the websites of national and international public health organizations, such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), to identify guidelines and protocols for pandemic surveillance. The results of our review provide an overview of the key principles and challenges of health communication in times marked by pandemic.